Emerging anticoagulant drugs.
The limitations of traditional anticoagulants, heparin and warfarin, have prompted the development of new anticoagulant drugs for prevention and treatment of both venous and arterial thromboembolism. After a brief review of thrombogenesis and its regulation, this study focuses on new anticoagulant agents in more advanced stages of clinical testing.
Bates
Shannon M
SM
Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Weitz
Jeffrey I
JI
D000818:Animals; D000925:Anticoagulants / Q000493:pharmacokinetics / Q000494:pharmacology; D000075202:Contraindications; D006801:Humans
D000925:Anticoagulants